Family with sequence similarity 217, member B (FAM217B) is a protein that, in humans, is encoded by the FAM217B gene. As a relatively recently characterized member of the human genome, the full extent of FAM217B's function and its biological significance are not completely understood, but emerging research is beginning to shed light on its potential roles in cellular physiology.The FAM217B protein belongs to a broader family of proteins, which are defined by shared sequence similarities. These proteins often have conserved domains or motifs that suggest common functions or interactions within cellular pathways. The "family with sequence similarity" nomenclature indicates that while the precise functions of these proteins may be diverse or not fully elucidated, they share genetic and structural features that hint at their evolutionary relationships and potential biological roles.
Initial studies and bioinformatic predictions suggest that FAM217B may be involved in intracellular processes such as signal transduction, gene regulation, or the maintenance of cellular structure and function. The protein may interact with other cellular components, influencing cell behavior, division, or response to external stimuliWith the advent of high-throughput sequencing and proteomics, proteins like FAM217B are increasingly coming under scrutiny to determine their specific functions. Aberrations in genes encoding such proteins could potentially be implicated in disease processes, and therefore, understanding their normal cellular roles is crucial for biomedical research.In summary, FAM217B represents a protein encoded by the human genome that shares sequence similarity with other family members, suggesting potential roles in key cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits phosphoinositide 3-kinases (PI3K), potentially affecting pathways that FAM217B may be involved in. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor, which could indirectly influence FAM217B activity in related signaling pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, affecting cellular growth and proliferation pathways, potentially influencing FAM217B. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, part of the MAPK/ERK pathway, which could indirectly affect FAM217B. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor, potentially influencing gene expression and pathways involving FAM217B. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, affecting gene expression, potentially impacting FAM217B. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor, potentially affecting protein degradation pathways that might influence FAM217B. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, altering signaling pathways that could be related to FAM217B's function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, potentially affecting pathways that intersect with FAM217B. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
Inhibits glycolysis, potentially impacting cellular energy metabolism and pathways involving FAM217B. | ||||||